# Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography

> **NCT05065073** · PHASE4 · UNKNOWN · sponsor: **Minneapolis Heart Institute Foundation** · enrollment: 62 (estimated)

## Conditions studied

- Coronary Artery Disease
- Contrast Media Reaction

## Interventions

- **DRUG:** Iodixanol
- **DRUG:** Iohexol

## Key facts

- **NCT ID:** NCT05065073
- **Lead sponsor:** Minneapolis Heart Institute Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-30
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2021-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05065073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05065073, "Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05065073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*